Matrix (Fentanyl)

Fentanyl is a potent synthetic opioid that acts as an agonist at the μ‑opioid receptors in the central nervous system. By binding these receptors, it inhibits the transmission of nociceptive signals and alters the perception of pain, producing analgesia and a sense of well‑being.

The specific dose of Matrix is determined by the prescribing clinician based on the patient’s opioid tolerance, pain severity, and clinical response. The prescriber selects the appropriate patch strength and duration, and the dosing regimen is individualized for each patient.

The safety of fentanyl transdermal patches during pregnancy or lactation has not been established. Because fentanyl can cross the placenta and be excreted in breast milk, it should be used only if the potential benefit justifies the potential risk to the fetus or infant, and only under close medical supervision.

To place an order, submit an enquiry on the Matrix product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with oral opioids, the fentanyl transdermal patch delivers a continuous, controlled dose, reducing the need for multiple daily administrations and improving adherence. Unlike morphine or oxycodone tablets, the patch bypasses gastrointestinal absorption, which can be advantageous for patients with nausea or vomiting, but it requires careful titration and monitoring.

Matrix patches should be stored at room temperature, below 30 °C, in their original sealed pouch, protected from direct sunlight, heat and moisture. Do not expose the patch to high humidity or temperatures above the recommended range, and keep it out of reach of children and pets.

The patch is applied to a clean, dry, hair‑free area of the upper torso or upper arm, avoiding scarred or irritated skin. Press firmly for about 30 seconds to ensure adhesion. After the prescribed wear time, remove the patch by peeling it off gently, fold it in half with the adhesive sides together, and dispose of it according to local hazardous‑waste regulations.

The most critical risks associated with fentanyl patches include respiratory depression, profound sedation, severe hypotension, and the potential for overdose if the patch is misused or applied to damaged skin. Patients should be educated to recognize signs such as shallow breathing, extreme drowsiness, or faintness and seek immediate medical attention if they occur.

Matrix should not be used in patients who are opioid‑naïve, have uncontrolled severe asthma, acute respiratory depression, or known hypersensitivity to fentanyl or any patch components. It is also contraindicated in individuals taking monoamine oxidase inhibitors within 14 days, or in those with significant head injury or increased intracranial pressure.